Inflammatix
Interpreting the immune response to better diagnose disease
San Francisco Bay Area, United States · Founded 2016
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- inflammatix.com
- Last Round
- Series ESep 2024
- Rounds
- 5
About
Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. Its TriVerity test provides three actionable scores — bacterial infection likelihood, viral infection likelihood, and illness severity — empowering emergency clinicians to make faster, more confident decisions.
Summary
Inflammatix is a Healthcare company based in San Francisco Bay Area, United States, founded in 2016. Its most recent funding was a Series E round in Sep 2024. Investors include Northpond Ventures, D1 Capital Partners and Khosla Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditio...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...